Примери за използване на Intend to prescribe на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
All physicians who intend to prescribe Soliris must ensure they are familiar with the physician's guide to prescribing. .
The MAH shall ensure that in each Member State(MS) where Mayzent is marketed,all physicians who intend to prescribe Mayzent are provided with an updated Physician Education Pack, including.
All physicians who intend to prescribe TYSABRI must ensure they are familiar with the Physician Information and Management Guidelines.
The MAH shall ensure that in each Member State(MS) where GILENYA is marketed,all physicians who intend to prescribe GILENYA are provided with an updated Physician Information Pack, including.
All physicians who intend to prescribe Provenge must review the educational materials and sign the training verification form.
The MAH shall develop an educational programme for Remicade to include paediatric Crohn' s disease patients to ensure that physicians who intend to prescribe Remicade to these patients are aware of.
Prior to launch, all doctors and pharmacists who intend to prescribe or dispense Thalidomide Celgene receive a Dear Healthcare Professional letter as described below.
Additional risk minimisation measures The Marketing Authorisation Holder(MAH)shall develop an educational programme for Xyrem to ensure that physicians who intend to prescribe Xyrem are aware about the posology of Xyrem and about the important risks.
All physicians who intend to prescribe Zinbryta must ensure they are familiar with the Hepatic Risk Management Guide for Physicians for this medicinal product.
The MAH shall ensure that prior to prescribing all healthcare professionals who intend to prescribe and/or dispense Opsumit are provided with a Prescriber Kit containing the following.
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE ADDRESSED BY THE MEMBER STATES The Member States should ensure that the MAH provides an educational programme for Remicade to ensure that physicians who intend to prescribe Remicade to paediatric Crohn's disease patients are aware of.
The Marketing Authorisation provides all physicians who intend to prescribe TYSABRI with a physician pack containing the following elements.
The Member States shall agree the details educational materials with the MAH according to national regulations and healthcare systems andensure that it is implemented nationally so that all health care professionals who intend to prescribe and/or dispense PhotoBarr are provided with the following.
Prior to launch, all doctors who intend to prescribe pomalidomide and all pharmacists who may dispense pomalidomide receive a Direct Healthcare Professional Communication as described below.
The Member States should ensure that the MAH provides an educational programme for Remicade to ensure that physicians who intend to prescribe Remicade to paediatric Crohn' s disease patients are aware of.
The MAH shall ensure that prior to launch, all doctors who intend to prescribe Tasigna, and all pharmacists who may dispense Tasigna, are provided with a healthcare professional information pack containing the following.
The Marketing Authorisation Holder must, following discussions and agreement with the National Competent Authorities in each Member State where TYSABRI is marketed,ensure that all physicians who intend to prescribe TYSABRI are provided with a physician pack containing the following elements.
The programme is also aimed at ensuring that the healthcare professionals who intend to prescribe Roteas are aware of the Patient alert card and that the card is to be given to and reviewed with all patients treated with Roteas.
The MAH must agree the details of a controlled distribution system with the National Competent Authorities and must implement such programme nationally to ensure that, prior to prescribing, all doctors who intend to prescribe Thelin are provided with a physician information pack containing the following.
The MAH shall ensure that prior to launch, all doctors who intend to prescribe the medicinal product, and all pharmacists who may dispense the medicinal product, are provided with a healthcare professional information pack containing the following.
Prior to prescribing(where appropriate, and in agreement with the National Competent Authority, dispensing)all healthcare professionals who intend to prescribe(and dispense) pomalidomide are provided with a physician information pack containing the following.
O Prior to prescribing all healthcare professionals who intend to prescribe(and in agreement with the National Competent Authority, dispense) Thalidomide Celgene are provided with an Educational Healthcare Professional's Kit containing the following: Healthcare professional booklet Patient booklets Patient cards Summary of Product Characteristics.
The MAH shall agree the details of a controlled distribution system with the National Competent Authorities andmust implement such programme nationally to ensure that prior to prescribing all health care professionals who intend to prescribe and/or dispense Tracleer are provided with a Prescriber Kit containing the following.
In particular, information will be provided for doctors who intend to prescribe the medicine to children with Crohn's disease or ulcerative colitis, to explain that these patients may be at an increased risk of developing infections and to remind of the importance of keeping vaccinations up to date.
The Marketing Authorisation Holder(MAH) shall agree the details of a controlled distribution system for the 20 ml vial of Revatio 0.8 mg/ml solution for injection with the National Competent Authorities andmust implement such programme nationally to ensure that prior to prescribing all healthcare professionals who intend to prescribe and/or dispense Revatio 0.8 mg/ml solution for injection are provided with the following.
In particular, information will be provided for doctors who intend to prescribe the medicine to children with Crohn's disease or ulcerative colitis, to explain that these patients may be at an increased risk of developing infections and to remind of the importance of keeping vaccinations up to date.
The Member States shall agree the details of a controlled distribution system with the MAH according to national regulations and healthcare systems and must implement such programme nationally to ensure that:o Prior to launch, all doctors and pharmacists who intend to prescribe or dispense Thalidomide Celgene receive a Dear Healthcare Professional letter as described below.
The MAH shall ensure that prior to launch, all doctors who intend to prescribe Tasigna, and all pharmacists who may dispense Tasigna, are provided with a healthcare professional information pack containing the following:• Educational brochure• Summary of Product Characteristics(SPC) and Package Leaflet and Labelling.
The MAH must agree the details of a controlled distribution system with the National Competent Authorities and must implement such programme nationally to ensure that, prior to prescribing, all doctors who intend to prescribe Thelin are provided with a physician information pack containing the following:• Product information• Physician information about Thelin• Patient information card• Partner of patient information card.
Prior to prescribing all healthcare professionals who intend to prescribe(and in agreement with the National Competent Authority, dispense) Thalidomide Celgene are provided with an Educational Healthcare Professional's Kit containing the following: o Educational healthcare professional booklet o Educational brochures for patient o Patient cards o Summary of product characteristics, package leaflet and labelling.